{"id":"W4410811746","doi":"10.1002/jha2.70061","title":"Efficacy of Total‐Body Irradiation‐based Intensified Myeloablative Regimens for Acute Leukemia—An International Collaborative Study","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; MorphoSys; National Cancer Institute; Servier; Teijin Pharma; Otsuka Pharmaceutical; Meiji Seika Pharma; JCR Pharmaceuticals; Health Resources and Services Administration; Syndax Pharmaceuticals; Astellas Pharma; Eisai; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Omeros Corporation; Vertex Pharmaceuticals; Atara Biotherapeutics; Actinium Pharmaceuticals; Regeneron Pharmaceuticals; Medical College of Wisconsin; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; BeiGene; Chugai Pharmaceutical; National Marrow Donor Program; HistoGenetics; Fuji Pharma; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Nippon Shinyaku; Gateway for Cancer Research; CSL Behring; Bristol-Myers Squibb; Amgen; Novartis Pharma; AbbVie; Kyowa Hakko Kirin; Sanofi","keywords":"Total body irradiation; Medicine; Internal medicine; Etoposide; Cytarabine; Hazard ratio; Hematopoietic stem cell transplantation; Cohort; Myeloid leukemia; Cyclophosphamide; Transplantation; Acute leukemia; Leukemia; Gastroenterology; Oncology; Surgery; Chemotherapy; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002602822,0.0001665378,0.0003999991,0.0002743297,0.00006483719,0.00001723065,0.0001133561,0.00008506875,0.00006497478],"category_scores_gemma":[0.0002493811,0.0001555292,0.00008556336,0.0004661315,0.0000698331,0.000119458,0.00001547433,0.0001137145,0.000009314399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000261294,"about_ca_system_score_gemma":0.0005651279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002824483,"about_ca_topic_score_gemma":0.00001457176,"domain_scores_codex":[0.9986824,0.0000829198,0.0004531652,0.0003326762,0.0002880935,0.0001607052],"domain_scores_gemma":[0.9981469,0.0004787352,0.0001726767,0.0003243684,0.0008020223,0.00007529252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.09325904,0.01779723,0.1868594,0.00208214,0.02831543,0.0006276779,0.2037526,0.006716944,0.3569696,0.06238922,0.02220279,0.01902794],"study_design_scores_gemma":[0.04386493,0.003940027,0.7406503,0.0008033169,0.002895436,0.00002498924,0.01666373,0.0286869,0.160366,0.0003234511,0.001252826,0.0005281271],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979237,0.00001750109,0.01061618,0.0009868543,0.0005444498,0.002706055,0.0001482607,0.00007424826,0.005669447],"genre_scores_gemma":[0.9933367,0.000004850946,0.003917785,0.0002579358,0.00007039482,0.0001614569,0.0003806555,0.00001979557,0.001850384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5537909,"threshold_uncertainty_score":0.6342295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02073038580851969,"score_gpt":0.3522462305389583,"score_spread":0.3315158447304385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}